Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 5 de 5
1.
Pathology ; 53(2): 257-263, 2021 Feb.
Article En | MEDLINE | ID: mdl-33036769

Trichomonas vaginalis (TV) infection is the leading cause of non-viral sexually transmitted infection (STI) globally and is endemic in rural and remote Australia. However, current accurate prevalence data for TV in urban Australia are scarce as TV is not a notifiable infection outside of the Northern Territory (NT). This study evaluated Australian guidelines for TV testing and determined TV prevalence among patients at a large urban public hospital in Melbourne, Australia. A retrospective analysis of genitourinary samples screened for STIs by multiplex polymerase chain reaction (MPCR) between May 2017 and April 2019 was performed. A total of 7155 results (5064 females) were included in the analysis. A prevalence for TV of 1.7% (n=123) was found, which was higher than Neisseria gonorrhoeae (1.4%, n=103) but less than Chlamydia trachomatis (5%, n=358). The highest rate of TV (3%) was found in females aged 30-44 years (n = 48). Routine MPCR improved TV detection almost six-fold compared with clinician request based testing. Current targeted testing guidelines for TV were inadequate for case finding in an urban setting, and clinical request among symptomatic patients was rare. MPCR testing provides a comprehensive testing strategy for curable STI, and removes the need for clinical suspicion of TV. Implementation of MPCR for STI screening can improve TV detection in populations not normally suspected to be at risk and therefore potentially reduce disease transmission or complications associated with undiagnosed infection.


Trichomonas Infections , Trichomonas vaginalis/isolation & purification , Adolescent , Adult , Aged , Australia/epidemiology , Child , Child, Preschool , Diagnostic Tests, Routine , Female , Genes, Protozoan , Humans , Infant , Male , Middle Aged , Multiplex Polymerase Chain Reaction , Northern Territory/epidemiology , Prevalence , Retrospective Studies , Rural Population , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/epidemiology , Trichomonas Infections/diagnosis , Trichomonas Infections/epidemiology , Trichomonas Infections/transmission , Trichomonas vaginalis/genetics
2.
Ann Clin Biochem ; 56(2): 275-282, 2019 03.
Article En | MEDLINE | ID: mdl-30674211

BACKGROUND: Clinical laboratory instrument verification testing is often an accreditation requirement. However, it is not known what verification procedures are in routine use or how often the process identifies problems which need addressing prior to testing clinical samples. OBJECTIVE: To investigate which standards are currently being used for laboratory verification in UK and New Zealand (NZ) clinical laboratories and to help establish if the activity justifies the effort required. METHODS: A survey of verification of clinical laboratory instrumentation was distributed to members of the Association for Clinical Biochemistry and Laboratory Medicine and New Zealand Institute of Medical Laboratory Scientists. The survey consisted of questions on the verification elements used and whether acceptance criteria were met. RESULTS: Nineteen of 72 (26%) of responders only used organization-developed protocols for verification, 20/72 (28%) solely used national/international guidelines, while 16/72 (22%) used a combination. Manufacturers' claims were partly or entirely used as acceptance criteria for imprecision (89%), accuracy (64%) and analytical measuring range (94%), with these being met on 61%, 67% and 93% of occasions, respectively. For patient comparison and linearity, acceptance criteria were met by 71% and 91%. Only 27-36% undertook any troubleshooting before accepting a failed component of verification. CONCLUSIONS: Laboratories in the UK and NZ are currently using a variety of verification standards and acceptance criteria for instrument verification. It is common for instruments to fail, especially following the assessment of imprecision and accuracy. While this suggests the process is warranted, only a minority address failed elements before accepting verification.


Clinical Laboratory Techniques/instrumentation , Surveys and Questionnaires , Clinical Laboratory Techniques/standards , New Zealand , Quality Control , United Kingdom
3.
J Water Health ; 12(3): 484-91, 2014 Sep.
Article En | MEDLINE | ID: mdl-25252352

Agricultural runoff into surface water is a problem in Australia, as it is in arguably all agriculturally active countries. While farm practices and resource management measures are employed to reduce downstream effects, they are often either technically insufficient or practically unsustainable. Therefore, consumers may still be exposed to agrichemicals whenever they turn on the tap. For rural residents surrounded by agriculture, the link between agriculture and water quality is easy to make and thus informed decisions about water consumption are possible. Urban residents, however, are removed from agricultural activity and indeed drinking water sources. Urban and rural residents were interviewed to identify perceptions of agriculture's impact on drinking water. Rural residents thought agriculture could impact their water quality and, in many cases, actively avoided it, often preferring tank to surface water sources. Urban residents generally did not perceive agriculture to pose health risks to their drinking water. Although there are more agricultural contaminants recognised in the latest Australian Drinking Water Guidelines than previously, we argue this is insufficient to enhance consumer protection. Health authorities may better serve the public by improving their proactivity and providing communities and water utilities with the capacity to effectively monitor and address agricultural runoff.


Agriculture , Attitude , Drinking Water , Water Quality , Adolescent , Adult , Aged, 80 and over , Drinking Water/standards , Female , Humans , Male , Middle Aged , New South Wales , Surveys and Questionnaires , Victoria , Water Quality/standards
4.
Infect Immun ; 71(6): 3000-9, 2003 Jun.
Article En | MEDLINE | ID: mdl-12761076

During the process of bloodfeeding by Anopheles stephensi, mammalian latent transforming growth factor beta1 (TGF-beta1) is ingested and activated rapidly in the mosquito midgut. Activation may involve heme and nitric oxide (NO), agents released in the midgut during blood digestion and catalysis of L-arginine oxidation by A. stephensi NO synthase (AsNOS). Active TGF-beta1 persists in the mosquito midgut to extended times postingestion and is recognized by mosquito cells as a cytokine. In a manner analogous to the regulation of vertebrate inducible NO synthase and malaria parasite (Plasmodium) infection in mammals by TGF-beta1, TGF-beta1 regulates AsNOS expression and Plasmodium development in A. stephensi. Together, these observations indicate that, through conserved immunological cross talk, mammalian and mosquito immune systems interface with each other to influence the cycle of Plasmodium development.


Anopheles/immunology , Anopheles/parasitology , Penicillamine/analogs & derivatives , Plasmodium falciparum/growth & development , Transforming Growth Factor beta/physiology , Animals , Humans , Intestinal Mucosa/metabolism , Malaria/transmission , Nitric Oxide/biosynthesis , Nitric Oxide Synthase/biosynthesis , Penicillamine/pharmacology , Peroxynitrous Acid/pharmacology , Transforming Growth Factor beta1
...